Overview and Scope
The dyslexia treatment market consists of revenues earned by entities by services such as literacy programs, multisensory interventions, assistive technologies, individualized education plans, cognitive training, and therapies targeting visual and auditory processing skills. The market value includes the value of related goods sold by the service provider or included within the service offering. The dyslexia treatment market also includes sales of assistive listening devices, phonological processing tools, digital pens and notetaking devices, eye-tracking devices, and multi-sensory learning tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Sizing and Forecast
The dyslexia treatment market size has grown strongly in recent years. It will grow from $26.36 billion in 2023 to $28.14 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to global collaboration and sharing of best practices, shifting societal attitudes towards learning disabilities, adoption of comprehensive treatment plans that incorporate psychological, educational, and medical interventions, enhanced funding from government and private sectors for research and educational programs, implementation of laws and regulations mandating support for students with learning disabilities.
The dyslexia treatment market size is expected to see strong growth in the next few years. It will grow to $37.06 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing awareness about dyslexia among parents, implementation of inclusive education policies and specialized educational programs for dyslexic students, an increase in the diagnosed cases of dyslexia, continuous training and development programs for educators and therapists, the rise of telehealth and online therapy services. Major trends in the forecast period include artificial intelligence tools for early diagnosis and customized treatment plans, the use of software-based interventions, the use of real-time brain activity monitoring to help individuals improve their reading skills, advanced speech-to-text applications to aid in reading and writing for dyslexic users, demand for devices that monitor cognitive functions and provide feedback to support learning and concentration.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/dyslexia-treatment-global-market-report
Segmentation & Regional Insights
The dyslexia treatment market covered in this report is segmented –
1) By Type: Double Deficit Dyslexia, Visual Dyslexia, Phonological Dyslexia, Other Types
2) By Therapy: Occupational Therapy, Speech Therapy, Cognitive Behavioural Therapy
3) By Drugs: Cyclizine, Meclizine, Dimenhydrinate, Methylphenidate, Other Drugs
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End Users: Psychiatric Institutions, Rehabilitation Centres, Home Care, Other End-users
North America was the largest region in the dyslexia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dyslexia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16402&type=smp
Major Driver Impacting Market Growth
An increase in the prevalence of neurological disorders is expected to propel the growth of the dyslexia treatment market going forward. Neurological disorders are medical conditions that affect the nervous system, including the brain, spinal cord, and nerves. The prevalence of neurological disorders is increasing due to factors such as an aging population, lifestyle changes, environmental factors, and improved diagnostic techniques that lead to better detection and reporting of these conditions. Dyslexia treatments, such as multisensory learning and cognitive training, show the potential to improve neurological disorders by enhancing brain plasticity and cognitive functions. For instance, in March 2024, according to the according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 3 billion people globally were living with a neurological condition. Additionally, over 80% of deaths and health losses due to neurological conditions occur in low- and middle-income countries. Access to treatment varies significantly, with high-income countries having up to 70 times more neurological professionals per 100,000 people than low- and middle-income countries. Therefore, an increase in the prevalence of neurological disorders is driving the growth of the dyslexia treatment market.
Key Industry Players
Major companies operating in the dyslexia treatment market are Pfizer Inc., Astrazeneca Plc, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma, Apotex Corporation, Endo International Plc, Amneal Pharmaceuticals LLC, Unither Pharmaceuticals LLC, RPG Life Sciences Ltd., Jubilant Pharma Limited, Breckenridge Pharmaceutical Inc., Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd, Lexia Learning Systems LLC, Wallace Pharmaceuticals Ltd., Ironshore Pharmaceuticals Inc., DK Pharmachem Pvt Ltd., Speechify Inc., Lingit AS, Lyfta, Nessy Learning Ltd.
The dyslexia treatment market report table of contents includes:
1. Executive Summary
2. Dyslexia Treatment Market Characteristics
3. Dyslexia Treatment Market Trends And Strategies
4. Dyslexia Treatment Market – Macro Economic Scenario
5. Global Dyslexia Treatment Market Size and Growth
.
.
.
32. Global Dyslexia Treatment Market Competitive Benchmarking
33. Global Dyslexia Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Dyslexia Treatment Market
35. Dyslexia Treatment Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
